"GLOBAL STRATEGIES AND CLINICAL APPROACHES TO STREPTOCOCCAL AND STAPHYLOCOCCAL INFECTIONS"

Authors

  • Jurayeva Muxabbat Ergashevna Author
  • Ahmedova Saodat Toshboltayevna Author

Abstract

This scientific article discusses in detail the etiology, pathogenesis, clinical manifestations, diagnostic methods and modern treatment strategies of streptococcal and staphylococcal infections, which are widespread and of high clinical importance in the human body. Streptococcus and staphylococcus are opportunistic microorganisms that cause severe, life-threatening infections not only in the skin and mucous membranes, but also in the respiratory tract, blood, heart valves, bone tissue and in patients with reduced immunity. Due to the sharp increase in the level of antibiotic resistance of these bacteria in recent years, their detection and treatment remains an urgent problem for global medicine.

References

1. World Health Organization (WHO). Global priority list of antibiotic-resistant bacteria. WHO Press. 2020.

2. Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States. CDC Report. 2019.

3. European Center for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe. ECDC Annual Report. 2022.

4. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 10th ed. Elsevier; 2021.

5. Dawn S.Y.C. et al. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2019;32(3):e00035-19. DOI: 10.1128/CMR.00035-19

6. Walker M.J. et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clinical Microbiology Reviews. 2014;27(2):264–301. DOI: 10.1128/CMR.00101-13

7. Liu C. et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) for the treatment of MRSA infections in adults and children. Clinical Infectious Diseases. 2018;52(3):e18–e55.

8. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. Clinical and Laboratory Standards Institute. 2021.

9. Chambers H.F., DeLeo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology. 2020;18(9):555–569.

10. Shulman S.T. et al. Clinical practice guideline for the diagnosis and management of streptococcal pharyngitis. Clinical Infectious Diseases. 2019;68(5):e1–e40.

11. Ventola C.L. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015;40(4):277–283.

12. Tacconelli E. et al. Discovery, research, and development of new antibiotics: WHO priority pathogens. Lancet Infectious Diseases. 2018;18(3):318–327.

13. Foster T.J. Antibiotic resistance in Staphylococcus aureus. Journal of Clinical Investigation. 2017;127(7):2383–2392.

14. National Health Service of the Republic of Uzbekistan. National Guide to the Rational Use of Antimicrobial Drugs. Tashkent, 2021.

15. National Health Service of the Republic of Uzbekistan. Clinical Protocol for the Diagnosis and Treatment of Streptococcal and Staphylococcal Infections. Tashkent, 2022.

Published

2025-10-12